All In Biotech

Drug Trial Radar · NCT00282828

Improving Treatment Outcomes in Pharmacotherapy of Generalized Social Anxiety Disorder

Improving Outcomes in Pharmacotherapy of Social Phobia

Last checked: Nov 20, 2026Latest source record: Oct 14, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 397 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

397

Actual

Start

Mar 2006

Primary completion

Dec 2011

Study completion Dec 2011

Sponsor

Lead sponsor
Massachusetts General HospitalAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Mental Health (NIMH)
First posted
Jan 27, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 4
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study will compare the effectiveness of either adding clonazepam or placebo to standard treatment or switching to venlafaxine in treating generalized social anxiety disorder in individuals who have not responded to treatment with sertraline.

Conditions

  • Social Phobia

Interventions

  • SertralineDrug

  • VenlafaxineDrug

  • PlaceboDrug

  • ClonazepamDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Rates of Remission (LSAS≤30) After 12 Weeks of Randomized Treatment During Phase II, Among Phase I Non-respondersTime frame: Measured at Week 22 (Endpoint)

Locations

3 sites in 2 countries. Site status is shown where the registry gives one.

  • University of California San Diego

    La Jolla, California

  • Center for Anxiety and Traumatic Stress Disorders

    Boston, Massachusetts

  • McMaster University Medical Centre Anxiety Disorders Clinic

    Hamilton, Ontario, Canada

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.